Close

Select Medical Holdings Corporation Announces Results for Third Quarter Ended September 30 2015

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Siemens, Prisma Health Value Partnership Boost...

Based in Greenville, USA, Siemens Healthineers, Prisma Health are...

Omega Healthcare Expands Collaboration with Microsoft...

Omega Healthcare, a leading provider of technology-enabled RCM services,...

Haleon Breaks Ground on new £130m...

This week, Haleon, a global leader in consumer health...

Evonik Opens New Medical Device Center...

The company’s largest center for medical device applications,...
Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced results for its third quarter ended September 30, 2015.
For the third quarter ended September 30, 2015, net operating revenues increased 34.7% to $1,021.1 million, compared to $758.1 million for the same quarter, prior year.  Income from operations was $48.2 million for the third quarter ended September 30, 2015, compared to $66.0 million for the same quarter, prior year.  Income before income taxes included a non-operating, one-time gain of $29.6 million on the sale of an equity investment in the third quarter ended September 30, 2015. Net income attributable to Select Medical was $29.4 million for the third quarter ended September 30, 2015, compared to $26.5 million for the same quarter, prior year.  Net income before interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, Concentra acquisition costs, equity in earnings (losses) of unconsolidated subsidiaries, and gain on sale of equity investment ("Adjusted EBITDA") for the third quarter ended September 30, 2015 decreased to $84.5 million, compared to $86.8 million for the same quarter, prior year.  A reconciliation of net income to Adjusted EBITDA is presented in table VIII of this release. Income per common share for the third quarter ended September 30, 2015 was $0.22 on a fully diluted basis compared to income per common share of $0.20 for the same quarter, prior year. 

Latest stories

Related stories

Siemens, Prisma Health Value Partnership Boost with $50m

Based in Greenville, USA, Siemens Healthineers, Prisma Health are...

Haleon Breaks Ground on new £130m Global Oral Health Innovation Centre

This week, Haleon, a global leader in consumer health...

Evonik Opens New Medical Device Center in Shanghai

The company’s largest center for medical device applications,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back